Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459972) titled 'Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis' on March 4.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Kafrelsheikh University
Condition:
Liver Cirrhosis
Portal Hypertension Related to Cirrhosis
Intervention:
Drug: Simvastatin 15 mg
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: March 15, 2024
Target Sample Size: 22
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov...